![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 31, 29188-29194, August 3, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
§,
,
, and
¶**
From the
Howard Hughes Medical Institute,
¶ Department of Pharmacology, and
Medical Scientist
Training Program and Biomedical Sciences Graduate Program, University
of California, San Diego, La Jolla, California 92093-0647
Received for publication, March 29, 2001
| |
ABSTRACT |
|---|
|
|
|---|
Yellow mutants of the green
fluorescent protein (YFP) are crucial constituents of genetically
encoded indicators of signal transduction and fusions to monitor
protein-protein interactions. However, previous YFPs show excessive pH
sensitivity, chloride interference, poor photostability, or poor
expression at 37 °C. Protein evolution in Escherichia
coli has produced a new YFP named Citrine, in which the mutation
Q69M confers a much lower pKa (5.7) than for
previous YFPs, indifference to chloride, twice the photostability of
previous YFPs, and much better expression at 37 °C and in
organelles. The halide resistance is explained by a 2.2-Å x-ray
crystal structure of Citrine, showing that the methionine side chain
fills what was once a large halide-binding cavity adjacent to the
chromophore. Insertion of calmodulin within Citrine or fusion of cyan
fluorescent protein, calmodulin, a calmodulin-binding peptide and
Citrine has generated improved calcium indicators. These chimeras can
be targeted to multiple cellular locations and have permitted the first
single-cell imaging of free [Ca2+] in the Golgi. Citrine
is superior to all previous YFPs except when pH or halide sensitivity
is desired and is particularly advantageous within genetically encoded
fluorescent indicators of physiological signals.
Yellow fluorescent proteins
(YFPs)1 were created (1) by
mutating Thr203 of the Aequorea victoria green
fluorescent protein (GFP) (2) to aromatic amino acids, typically Tyr.
The resulting Measurements of FRET between CFP and YFP are becoming increasingly
common to monitor protein-protein interactions nondestructively in live
cells (5, 13, 17). The potential partners are fused to CFP and YFP,
respectively, and coexpressed in cells. Because FRET requires that the
CFP and YFP be within a few nanameters of each other, it can detect
proximity at molecular dimensions, with 2 orders of magnitude higher
spatial resolution than simple co-localization of the two colors. This
approach has been used to monitor interactions of nuclear receptors and
coactivators (18), nuclear transport factors (19), protein kinase A and anchoring proteins (20), G-protein subunits (21), G-protein-coupled receptors (22), and cytokine receptors (23). FRET can also detect
intramolecular conformational changes, particularly within genetically
encoded fluorescent indicators for a wide variety of intracellular
analytes and processes such as Ca2+ (8, 24-26),
(Ca2+)4-CaM (27), Zn2+ (5), NO
(28), cGMP (29, 30), protease activation (31, 32), and protein kinase
A-dependent phosphorylation (33).
Genetically encoded indicators offer the major advantages of versatile
and modular construction, applicability to intact transgenic organisms,
and precise targetability to specific tissues, organelles, and
subcellular microenvironments. These advantages are particularly important for Ca2+ indicators, which have been the subject
of more effort than any of the other indicator classes. Both
ratiometric and non-ratiometric indicators of Ca2+ have
been constructed from CFP, GFP, or YFP (2) as fluorophores and
calmodulin as calcium binding moiety in several configurations. In
cameleons (26), an N-terminal CFP is fused to calmodulin, the
calmodulin-binding peptide M13 from myosin light chain kinase, and a
C-terminal YFP. Binding of Ca2+ to calmodulin leads to a
conformational change that enhances the fluorescence resonance energy
transfer (FRET) from the shorter wavelength emitting CFP to the longer
wavelength emitting YFP. Subsequent modifications in the YFP acceptor
protein led to improved cameleons with decreased sensitivity to
cytosolic pH changes (8). The YFP portion of these improved cameleons
(termed EYFP V68L/Q69K) had a pKa of 6.1, rendering
it largely insensitive to pH changes near neutrality. However, due to
poor folding at 37 °C, specific targeting was hard to achieve.
In a different approach, calmodulin was directly inserted into the
backbone of YFP in place of Tyr145 to generate a medium
affinity Ca2+ indicator termed camgaroo-1 that increased
fluorescence intensity ~8-fold upon saturation with Ca2+
(34). A problem with this non-ratiometric indicator was that the
fluorescence of the indicator in transfected cells at resting Ca2+ levels was almost zero, making it difficult to
identify transfected cells for experiments. Also, the protein did not
express well at 37 °C.
In an effort to overcome these problems, we undertook an expression
screen in Escherichia coli and identified an improved mutant
of YFP, consisting of GFP with mutations S65G/V68L/Q69M/S72A/T203Y. For
brevity we have named this mutation Citrine to reflect its yellow color
and acid resistance. Citrine folds well at 37 °C, can be targeted to
subcellular compartments, and has a pKa of 5.7. Some
aspects of the photophysics of Citrine, including two-photon spectra,
light-driven flickering, excitation state decay kinetics, and
translational and rotational diffusion were recently described (35),
but these measurements were wholly in vitro, did not
document the superiority of Citrine over previous YFPs, and did not
explain why the Q69M mutation conferred beneficial properties. Using
Citrine, we have now constructed new genetic indicators of cellular
Ca2+ dynamics and assessed their properties with respect to
pH interference, folding, and targeting in mammalian cells. In
addition, we have determined the 2.2-Å x-ray structure of Citrine and
propose a structural explanation for the various improvements conferred upon Citrine by the Q69M mutation.
Error-prone PCR and Bacterial Colony Screening--
cDNA
encoding camgaroo-1 (34) in the vector pRSETB (Invitrogen)
was subjected to error-prone PCR using Taq polymerase. The 5' primer included a BamHI site and ended at the starting
Met of the GFP, and the 3' primer included an EcoRI site and
ended at the stop codon, theoretically allowing mutagenesis of every base of camgaroo-1 other than Met1. The PCR (38 cycles with annealing at 55 °C) was run in four 100-µl batches, each containing 10 µl of 10 × PCR buffer with Mg2+ (Roche Molecular
Biochemicals), 150 µM Mn2+, 250 µM of three nucleotides, 50 µM of the
remaining nucleotide, and 5 ng of template. Mutagenic PCR products were
combined, purified by agarose gel electrophoresis, digested with
BamHI and EcoRI, and repurified by QiaQuick
columns (Qiagen). The resulting fragment was ligated into
pRSETB, and the crude ligation mixture was transformed into
E. coli BL21(DE3) Gold (Stratagene) by electroporation.
Bacteria plated on LB/agar plates were imaged as described (34), and colonies that became fluorescent after overnight incubation at 37 °C
were grown in liquid culture and the plasmid DNA obtained by Miniprep
(Qiagen). Protein was expressed and purified as previously described
(34). Spectroscopy of purified protein was typically performed in 100 mM KCl, 10 mM MOPS, pH 7.25, in a fluorescence spectrometer (Fluorolog-2, Spex Industries). pH titrations were performed as described (34). All DNA sequencing was performed by the
Molecular Pathology Shared Resource, University of California, San
Diego, Cancer Center.
Gene Construction and in Vitro Characterization--
Mutations
Q69M (Citrine), C48L, and C70V were introduced into EYFP V68L/Q69K by
site-directed mutagenesis (QuikChange, Stratagene). To generate yellow
cameleon-2.3 (YC2.3) and YC3.3, Citrine was inserted into the
previously described cameleons YC2 and YC3 (26) in the cloning vector
pUC119, and then subcloned into the mammalian expression vector
pcDNA3 (Invitrogen). Targeting to the endoplasmic reticulum (ER)
was achieved by the calreticulin signal peptide and the KDEL
ER-retention sequence (36). Targeting to the medial/trans-Golgi was
achieved using the type II membrane-anchored protein
galactosyltransferase (GT), which has been used to target GFP to this
organelle (6). Mitochondrial targeting of camgaroo-2 was achieved by
replacing ECFP with the camgaroo-2 coding sequence in the pECFP-Mito
vector (CLONTECH), which uses the targeting
sequence of subunit VIII of cytochrome c oxidase. In order
to evaluate targeted expression of YFP mutants, identical amounts of
DNA (20 µg) of EYFP V68L/Q69K-ER, Citrine-ER, or Citrine C48L/C70V-ER
in pcDNA3 were transfected into HeLa cells (3 × 105 per 35-mm dish) with Lipofectin (Life Technologies,
Inc.). After 2 days of expression cells were suspended in Hanks'
balanced saline solution, normalized at
A600, and measured in the fluorescence spectrometer.
Single Cell Imaging--
Single HeLa cells were imaged with a
charge-coupled device camera (Photometrics, Tucson, AZ) as described
(26) at room temperature 1-5 days after transfection. The excitation
filter for ratiometric imaging was 440DF10 with a 455DCLP dichroic
mirror. The emission filters were 480DF30 (CFP) or 535DF25 (Citrine).
Experiments were processed digitally using Metafluor software version
2.75 or 4.01 (Universal Imaging, West Chester, PA). For imaging
camgaroo-2, a 480DF30 excitation filter was used in combination with a
fluorescein dichroic mirror and emission filter 535DF25.
Crystallization and Data Collection--
Citrine in vector
pRSETB was expressed in E. coli JM109(DE3) and
the protein purified as previously described (34). Following enterokinase (Invitrogen) catalyzed proteolysis of the 6-His tag, 1 ml
of Ni-NTA-agarose (Qiagen) was added to bind residual uncleaved protein
and 6-His peptides and the solution was gently agitated (4 °C for
2 h). Agarose resin was removed by filtration and the protein was
concentrated to 20 mg/ml with a Micron-30 (Amicon). Citrine was
crystallized by hanging drop vapor diffusion at 4 °C by addition of
equal volumes of protein and crystallization buffer (7% PEG 3400, 50 mM NH4OAc, 50 mM NaOAc, pH 5.0).
Crystals were visible after 3-4 days and grew to ~0.5 × 0.2 × 0.2 mm within 14 days. The crystals belong to space group
P212121 with unit cell dimensions of a = 52.50 Å,
b = 61.76 Å, and c = 70.68 Å and one
monomer per asymmetric unit. X-ray intensity data on a single crystal
were collected at room temperature on a Mar 345 image plate detector
(Mar Research) with a multilayer mirror monochromated CuK Refinement and Analysis--
The atomic coordinates of the
Protein Data Bank (PDB) entry 2YFP (3) with all solvent molecules, the
chromophore, and residue Gln 69 removed were used as the starting model
for refinement. The B factor for all atoms was set to 25 Å2. One round of rigid body refinement, simulated
annealing, and individual B factor refinement in CNS (38)
resulted in an Rfactor = 24% and an
Rfree = 29%. Refinement proceeded with
alternate rounds of manual adjustment in XTALVIEW (39) and simulated
annealing/B factor refinement in CNS. The stereochemistry of
the model was evaluated with PROCHECK (40). The most favored regions of
the Ramachandran plot contained 89.6% of the nonglycine residues with the remaining 10.4% in the additional allowed regions. Cavity volumes
were determined with MSMS (41).
Our newest and best YFP arose from efforts to improve camgaroo-1
(34), a genetically encoded Ca2+ indicator consisting of
Xenopus calmodulin inserted in place of residue 145 of
EYFP-Q69K (2). Camgaroo-1 had the desirable feature of a rather large
(~7-fold) increase in fluorescence in response to Ca2+
binding, but it unfortunately expressed poorly at 37 °C and could not be targeted to organelles such as mitochondria (34). We therefore
randomly mutated the cDNA encoding camgaroo-1 by error-prone PCR,
transformed the resulting library into E. coli, and screened colonies grown at 37 °C for maximal fluorescence. Sequencing of the
brightest clones (camgaroo-2) revealed just one new mutation, replacement of residue 69 (Gln in wild type, Lys in EYFP V68L/Q69K) by
Met. The excitation and emission maxima as well as the response to
in vitro titration with Ca2+ (5.3 ± 0.3 µM apparent dissociation constant, Hill coefficient 1.24, fluorescence enhancement of ~7-fold) (Fig.
1A) were much the same as for
camgaroo-1. However, camgaroo-2 produced far brighter expression in
HeLa cells grown at 37 °C, where it filled the cytosol and nucleus
uniformly (Fig. 1B). Stimulation of the cells with histamine
produced only about 5% intensity increase (Fig. 1C), consistent with the bias of camgaroos toward higher amplitude [Ca2+] transients. A saturating elevation of cytosolic
[Ca2+] induced with ionomycin increased the fluorescence
about 6-fold (Fig. 1C). We also targeted camgaroo-2 to
mitochondria using the pECFP-Mito vector
(CLONTECH), which uses the targeting sequence of
subunit VIII of cytochrome c oxidase. Transfected cells
showed a pattern typical of mitochondria (Fig. 1D),
indistinguishable from that of the accepted mitochondrial marker
rhodamine 123 (data not shown). Camgaroo-2 is functional in
mitochondria because a response to histamine was detected and ionomycin
produced a significant fluorescence increase, although lower in dynamic
range than in the cytosol (Fig. 1E).
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-
stacking and increased local polarizability
immediately adjacent to the chromophore are believed to be responsible
for the ~20-nm shift to longer excitation and emission wavelengths
(3). However, the changes in internal hydrogen bonding and steric
packing also made the fluorescence more vulnerable to photobleaching
(4, 5), decolorization by protonation (6-10), and quenching by many
anions (10-12), of which chloride is the physiologically most relevant. These sensitivities can be exploited for specialized applications such as measuring fluorescence recovery after
photobleaching and sensing pH and halide concentrations, but are
deleterious for using YFPs either as simple fusion tags or as acceptors
for fluorescence resonance energy transfer (FRET). YFPs are becoming very popular in such roles, particularly as partners for cyan fluorescent protein (CFP) mutants of GFP (2, 5, 13-15). CFPs and YFPs
are spectroscopically well enough separated to be easily distinguishable in either excitation or emission spectra, yet the
emission wavelengths of CFPs and excitation wavelengths of YFPs overlap
well enough to make them good partners for FRET. They have largely
superseded the initial pairing of blue mutants and improved green forms
of GFP (16), because the blue mutants were too dim and photobleachable,
and because shorter wavelengths generically excite more
autofluorescence and raise more concerns of phototoxicity.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
beam from
a Rigaku FR rotating anode x-ray generator with mirrors. The crystal
diffracted to 2.2-Å resolution with an Rmerge of 5.5 and 99.3% completeness with 4.8-fold redundancy. All data were
integrated and scaled with DENZO/SCALEPACK (37). The Wilson B factor is 29.7 Å2.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (29K):
[in a new window]
Fig. 1.
Camgaroo-2 in vitro and in
mammalian cells. A, fluorescence intensity (528 nm
emission, pH 7.25) as a function of free Ca2+
concentrations. B, unstimulated HeLa cells transfected with
cytosolic camgaroo-2, imaged at 480 nm excitation (30 nm band width)
with a fluorescein dichroic mirror, and emission at 535 nm (25 nm band
width). C, fluorescence changes in a HeLa cell expressing
cytosolic camgaroo-2 after given stimulations. The fluorescence F
normalized by the prestimulus fluorescence Fo is
plotted. D, HeLa cells transfected with camgaroo-2 targeted
to mitochondria at resting calcium levels. E, fluorescence
changes in a HeLa cell expressing mitochondria targeted camgaroo-2
after given stimulations.
The desirable effects of mutation Q69M in camgaroo-2 prompted transfer
of this same mutation into EYFP V68L/Q69K not containing any inserted
proteins. This improved variant of YFP, i.e. Citrine, has
excitation and emission peaks of 516 and 529 nm, respectively, a
quantum yield of 0.76, and an extinction coefficient of 7.7 × 104 (Table I). These
properties are comparable to those of previous YFPs. One unexpected
spectroscopic difference is that Citrine photobleaches at about half
the rate as EYFP V68L/Q69K (Fig.
2A). Based on the illumination
intensity of 1.9 W/cm2, we estimate the photobleaching
quantum yield of Citrine to be about 2.3 × 10
5, in
surprisingly good agreement with an estimate of 2.6 × 10
5 obtained at much higher illumination intensities
(35). The corresponding value for EYFP V68L/Q69K is 5 × 10
5 from Fig. 2A and Ref. 42. Citrine also has
a considerably lower pKa, 5.7, than previous YFPs
such as EYFP V68L/Q69K (Fig. 2B and Table I) making it less
sensitive to fluctuations in intracellular pH. Cytosolic pH can range
from ~7.3 to 6.8, depending on cell type and stimulation (43), so
cytosolic Citrine should not be expected to vary in fluorescence during
normal physiological stimulation. Furthermore, pH titrations were the
same in 100 mM potassium chloride and 100 mM
sodium gluconate (Fig. 2B), indicating that Citrine is not
perturbed by chloride. The pKa values of all
previous YFPs increase with increasing halide concentrations (10-12).
For example, Fig. 2B also shows the chloride dependence of
EYFP V68L/Q69K, which is actually one of the less halide-sensitive
YFPs. Citrine folded efficiently at 37 °C, and with appropriate
targeting sequences, could be expressed in the endoplasmic reticulum of
HeLa cells. In contrast, EYFP V68L/Q69K did not tolerate attachment of
ER-targeting sequences, and remained mostly nonfluorescent, with
sporadic cells showing cytosolic fluorescence (data not shown). In
addition, circular permutations of Citrine were observed to develop
fluorescence at 37 °C (Table I), in contrast to comparable
permutations of EYFP V68L/Q69K that become fluorescent only at 20 °C
or less. In summary, the Q69M mutation improves many of the
shortcomings of YFP including pH and chloride sensitivity as well as
the inability to fold well in organelles or as a circular
permutation.
|
|
To investigate why the mutation Q69M improves YFPs chloride and pH
resistance, we determined the x-ray structure of Citrine at 2.2-Å
resolution (Table II and PDB accession
code 1HUY). As expected, the effect of the Q69M mutation on the overall
structure of YFP is minor. The root mean square deviation between
Citrine and the same protein with Gln at 69 (PDB accession code 1YFP) is 0.32 Å (3). In the immediate vicinity of the chromophore and the
adjacent Met69 residue, small positional shifts (on the
order of 0.3 Å when compared with 1YFP) resulting from the
introduction of the bulky methionine side chain are apparent (Fig.
3A). There is a localized
slight outward displacement of the two closest strands of the
-barrel due to steric contact of the side chains of residues Val150 and Leu201 with the methionine.
Additional residues in the local environment, including the chromophore
and its
-stacked partner Tyr203, have undergone
compensatory shifts and thus the majority of the packing interactions
and hydrogen bond network are unchanged.
|
|
In previous YFPs, the pKa of the chromophore and the halide binding constant are interdependent such that protonation and halide binding facilitate each other. To explain this effect, it has been proposed that in the presence of halide, the anionic form of the chromophore is destabilized through suppressed de-localization of the negative charge (10). Conversely, neutralization of the chromophore would reduce electrostatic repulsion of an adjacent anion. Previous x-ray structural studies on YFP have shown that iodide binds in a large cavity adjacent to the chromophore and in close contact to the heterocyclic carbonyl oxygen of the chromophore (10). In the absence of halide, the binding cavity (55 Å3) is partially occupied by the side chain of Gln69 (Fig. 3B). In order to form the anion binding cavity, the side chain of this residue must undergo a conformational change and swing out of the cavity thereby expanding the cavity size (91 Å3) and positioning the nitrogen of the carboxamide such that it can hydrogen bond to the anion (Fig. 3C). In Citrine, Gln69 has been replaced with a Met that effectively fills the halide-binding cavity such that it is no longer accessible to a sphere with radius 1.2 Å (Fig. 3A). In the x-ray structure of Citrine, the Met is well ordered (Bav = 17.5 Å3) and there is no unexplained difference density in the region of the cavity. This suggests that the Met side chain is tightly packed into the cavity and likely unable to undergo a conformational change that would be analogous to that observed for Gln69 between the free and iodide bound forms of EYFP (10). Even if such a conformational change was permitted, it is unlikely that the thioether side chain of Met could contribute to the formation of a halide-binding site since it is incapable of hydrogen bonding in the same manner as the carboxamide nitrogen of a Gln side chain. The benefits of Q69M are not generalizable across GFP colors, because this mutation prevents CFPs from becoming fluorescent (results not shown). CFPs have bulkier chromophores based on Trp rather than Tyr at position 66, so their intolerance of increased adjacent bulk at position 69 is not surprising.
We wondered whether removal of the two cysteines in GFPs could further improve folding in the oxidative environment of the secretory pathway. For this purpose we introduced the mutations C48L and C70V into GFP mutants. These mutations had previously been found to be the least injurious replacements for the cysteines in GFP itself.2 When introduced into CFP or EYFP V68L/Q69K, these mutants retained fluorescence but became extremely temperature-sensitive and developed bright fluorescence only after overnight growth at 4 °C or room temperature. Cysteine-less Citrine was brightly fluorescent, folded well at 37 °C, and had spectroscopic properties similar to Citrine itself, with only a slight decrease in quantum yield and extinction coefficient (Table I). However, in HeLa cells, ER-targeted cysteine-less Citrine gave less fluorescence intensity and lower expression than ER-targeted Citrine containing cysteines, as verified by Western blot analysis. Therefore, the cysteines were left in Citrine for all subsequent constructs for either cytosolic or targeted expression.
We then set out to construct a series of improved genetic indicators
that incorporated Citrine in place of previous YFPs. Yellow cameleons
YC2.3 and YC3.3 are new ratiometric indicators of high and medium
calcium affinity based on previous cameleons (8, 26), but incorporating
Citrine as the FRET acceptor protein. The spectral changes in the
emission of purified YC3.3 from 100 µM EGTA to calcium
saturation were as expected (Fig.
4A), indicating that
substitution of EYFP V68L/Q69K with Citrine did not alter the
Ca2+-dependent FRET changes. The ratio of
528/476 nm emissions was stable down to approximately pH 6.5, and then
decreased with further acidification (Fig. 4B). The pH
effects were greatest at saturating Ca2+, at which FRET
from the relatively pH-insensitive CFP to the still somewhat
pH-sensitive Citrine is maximal. Nevertheless YC2.3 and 3.3 are more
resistant than any other cameleon to acidic pH. YC2.3 and YC3.3 were
brightly fluorescent when expressed in the cytosol of HeLa cells and
were homogenously distributed in the cytosol with the nucleus excluded,
as expected of a 74-kDa protein without targeting sequences. Responses
to submaximal doses of histamine were readily detected, and the maximal
ratio change obtained in cells was around 2-fold (data not shown),
similar to the results from previous cameleons (8).
|
The lower pKa of Citrine compared with previous YFPs
should allow imaging of free calcium transients in more acidic compartments that so far have been inaccessible to cameleons. For
example, the Golgi was reported to have a pH of 6.58 (6), which should
still be in the working range of our new cameleons. To test this we
targeted YC3.3 to the Golgi by fusing the 81 N-terminal amino acids of
human galactosyltransferase type II to YC3.3 and thereby generating
GT-YC3.3 (Fig. 5A).
Transfection of HeLa cells resulted in bright punctate labeling of
Golgi stacks in a juxtanuclear position (Fig. 5B), identical
to cells transfected with GT-EYFP or stained for the medial/trans-Golgi
marker
-mannosidase II (6). GT-YC3.3 was saturated at resting
conditions (Fig. 5C), indicating a high concentration of
free Ca2+ in the Golgi. Histamine (100 µM) caused a very
small decrease. The Golgi calcium store could be depleted with several
washes of ionomycin/EGTA and was refilled upon readmitting
extracellular calcium (Fig. 5C), demonstrating the
feasibility of single cell imaging of free calcium concentrations in
the Golgi of mammalian cells. It has to be kept in mind that ionomycin
does not perform optimally in acidic compartments. Also it should be
noted that YC3.3 is near its lower pH limit under these conditions.
Further improvements in pH resistance are still desirable, especially if one wants to study even more acidic compartments of interest such as
secretory vesicles. YC3.3 was similarly well expressed in the ER (data
not shown).
|
| |
DISCUSSION |
|---|
|
|
|---|
Citrine represents a third generation of YFPs or yellow mutants of
green fluorescent protein. The first generation was exemplified by
S65G/S72A/T203Y (26) and "10C" (1), S65G/V68L/S72A/T203Y. These
proteins proved to be quite sensitive to pH (e.g.
pKa 6.9-7.1) (6), halides such as Cl
(11) and partially reversible photobleaching (4). These sensitivities
have been useful for particular purposes such as quantifying cytosolic
pH (6), [Cl
] (12, 44), or FRET efficiency (18), but are
considerable nuisances whenever one simply wants to use YFP as a
reliable label or FRET acceptor. In a second generation, the mutation
Q69K was introduced into 10C to give S65G/V68L/Q69K/S72A/T203Y (8) or "EYFP V68L/Q69K," which lowered the pKa to 6.1 with little effect on the other sensitivities. We speculated that the
positively charged lysine might electrostatically hinder chromophore
protonation (8). The Q69K mutation also introduced a disadvantage:
folding became noticeably more difficult, especially in organelles at 37 °C. In the most recent version, Citrine, replacement of Q69K by
Q69M lowered the pKa yet further to 5.7, eliminated the halide sensitivity, doubled the photostability, and improved the
folding. The improvement in folding efficiency was particularly apparent in difficult cases such as functional expression at 37 °C
in organelles or with an internally inserted calmodulin,
i.e. camgaroo-2. The crystal structure provides some
reasonable rationalizations for these improved properties, in that the
Met side chain nicely plugs what had been a sizable halide-binding
cavity next to the chromophore. The poorer folding of Q69K might well
be due to the extra length of a Lys side chain making an uncomfortable
fit within the cavity, or the electrostatic penalty for burying a
positive charge, or both. Thus a good steric fit with a neutral side
chain seems far more effective at lowering the chromophore
pKa than an awkward fit with a positively charged
side chain. The apparent photobleaching of YFPs probably consists of
two components, a reversible proton redistribution or tautomerization
and a truly irreversible covalent reaction (4, 5). Either or both would be hindered by better packing of the hydrophobic core and elimination of a cavity next to the chromophore.
Despite the inferiority of Q69K, it was an essential stepping stone in the evolution of better properties by random mutagenesis and screening, because direct alteration of the Gln codon CAG to the Met codon ATG would require two base changes in a single codon, a very unlikely event. It was fortunate that there was an easy evolutionary path from CAG to the Lys codon AAG and then to ATG. Many other examples of optimal sequences may remain relatively inaccessible to random mutation due to barriers created by the genetic code.
We have demonstrated the application of Citrine in a series of genetically encoded Ca2+ indicators based on Citrine, all of which were improved in relation to their predecessors. Camgaroo-2 may constitute an alternative to cameleons in confocal microscopy given that it can be conveniently excited at the 488 nm argon laser line, or in cases in which targeting of cameleons are not successful. For example, we and others have found targeting of cameleons to mitochondria to be difficult (45), whereas camgaroo-2 was easy to send to the mitochondria with the targeting sequence of cytochrome c oxidase subunit VIII. Single cell imaging of mitochondrial calcium offers exciting new prospects for studying its dynamics in this organelle as well as to address aspects of heterogeneity of the mitochondrial population (46). Camgaroos lack a CaM-binding peptide and therefore have lower Ca2+ affinities than the newest generic design of GFP-based Ca2+ indicators, "G-CaMP" (47) or "pericams" (45). These indicators are chimeras of the CaM-binding peptide M13, circularly permuted GFP or YFP, and CaM. However, many of these molecules still do not express well at 37 °C, so annealing mutations corresponding to Q69M might well be worth incorporating.
Our new improved cameleons expressed well at 37 °C and were
successfully targeted to the ER and Golgi. Cytosolic pH fluctuations are readily transmitted to the ER (48), therefore it was important to
be able to express a pH-resistant functional indicator in this organelle, which had not been possible with previous versions of
cameleons. Similarly, previous cameleons did not allow imaging free
calcium in the Golgi due to the mild acidity of the compartment, which
quenched other YFPs. Little is known about calcium regulation in the
Golgi. One study using targeted aequorin identified the Golgi as a
major calcium store within the cell (49), but aequorin has many
disadvantages, such as lack of intrinsic fluorescence and requirement
for an exogenous cofactor, that limit its use as a reliable calcium
probe. We believe that Citrine should supersede previous YFPs within
fusions for multicolor observation of protein trafficking,
protein-protein interaction, and intramolecular conformational change,
especially within genetically encoded Ca2+ indicators.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Qing Xiong for skillful technical assistance and Nick Nguyen for assistance in x-ray data collection.
| |
FOOTNOTES |
|---|
* This work was supported in part by the Howard Hughes Medical Institute, National Institutes of Health Grant NS-27177, and a postdoctoral fellowship from the Canadian Institutes of Health Research (to R. E. C.). The University of California, San Diego Cancer Center, was supported in part by NCI, National Institutes of Health Support Grant 5P0CA23100-16.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The atomic coordinates and the structure factors (code 1HUY) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).
§ Contributed equally to the results of this work.
** To whom correspondence should be addressed: Dept. of Pharmacology and HHMI, University of California, La Jolla, CA 92093-0647. Tel.: 858-534-4891; Fax: 858-534-5270; E-mail: rtsien@ucsd.edu.
Published, JBC Papers in Press, May 31, 2001, DOI 10.1074/jbc.M102815200
2 R. Ranganathan, personal communication.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: YFP, yellow-emission variants of GFP; GFP, green fluorescent protein; CFP, cyan fluorescent protein; EYFP V68L/Q69K, GFP with mutations S65G/V68L/Q69K/S72A/T203Y; Citrine, GFP with mutations S65G/V68L/Q69M/S72A/T203Y; FRET, fluorescence resonance energy transfer; cameleon or YC, a protein construct consisting of CFP, calmodulin, M13, and YFP fused in sequence; camgaroo, a YFP with calmodulin inserted at position 145; ER, endoplasmic reticulum; PCR, polymerase chain reaction; MOPS, 4-morpholinepropanesulfonic acid; GT, galactosyltransferase.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Ormö, M., Cubitt, A. B., Kallio, K., Gross, L. A., Tsien, R. Y., and Remington, S. J. (1996) Science 273, 1392-1395 |
| 2. | Tsien, R. Y. (1998) Annu. Rev. Biochem. 67, 509-544 |
| 3. | Wachter, R. M., Elsliger, M.-A., Kallio, K., Hanson, G. T., and Remington, S. J. (1998) Structure 6, 1267-1277 |
| 4. | Dickson, R. M., Cubitt, A. B., Tsien, R. Y., and Moerner, W. E. (1997) Nature 388, 355-358 |
| 5. | Miyawaki, A., and Tsien, R. Y. (2000) Methods Enzymol. 327, 472-500 |
| 6. | Llopis, J., McCaffery, J. M., Miyawaki, A., Farquhar, M. G., and Tsien, R. Y. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 6803-6808 |
| 7. | Matsuyama, S., Llopis, J., Deveraux, Q. L., Tsien, R. Y., and Reed, J. C. (2000) Nat. Cell Biol. 2, 318-325 |
| 8. | Miyawaki, A., Griesbeck, O., Heim, R., and Tsien, R. Y. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 2135-2140 |
| 9. | Elsliger, M.-A., Wachter, R. M., Hanson, G. T., Kallio, K., and Remington, S. J. (1999) Biochemistry 38, 5296-5301 |
| 10. | Wachter, R. M., Yarbrough, D., Kallio, K., and Remington, S. J. (2000) J. Mol. Biol. 301, 157-171 |
| 11. | Wachter, R. M., and Remington, S. J. (1999) Curr. Biol. 9, R628-R629 |
| 12. | Jayaraman, S., Haggie, P., Wachter, R. M., Remington, S. J., and Verkman, A. S. (2000) J. Biol. Chem. 275, 6047-6050 |
| 13. | Tsien, R. Y., and Miyawaki, A. (1998) Science 280, 1954-1955 |
| 14. | Ellenberg, J., Lippincott-Schwartz, J., and Presley, J. F. (1999) Trends Cell Biol. 9, 52-56 |
| 15. | Green, G., Kain, S. R., and Angres, B. (2000) Methods Enzymol. 327, 89-94 |
| 16. | Heim, R., and Tsien, R. Y. (1996) Curr. Biol. 6, 178-182 |
| 17. | Zacharias, D. A., Baird, G. S., and Tsien, R. Y. (2000) Curr. Opin. Neurobiol. 10, 416-421 |
| 18. | Llopis, J., Westin, S., Ricote, M., Wang, J., Cho, C. Y., Kurokawa, R., Rose, D. W., Rosenfeld, M. G., Tsien, R. Y., and Glass, C. K. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 4363-4368 |
| 19. | Damelin, M., and Silver, P. A. (2000) Mol. Cell 5, 133-140 |
| 20. | Ruehr, M. L., Zakhary, D. R., Damron, D. S., and Bond, M. (1999) J. Biol. Chem. 274, 33092-33096 |
| 21. | Janetopoulos, C., Jin, T., and Devreotes, P. (2001) Science 291, 2408-2411 |
| 22. | Overton, M. C., and Blumer, K. J. (2000) Curr. Biol. 10, 341-344 |
| 23. | Siegel, R. M., Frederiksen, J. K., Zacharias, D. A., Chan, F. K. M., Johnson, M., Lynch, D., Tsien, R. Y., and Lenardo, M. J. (2000) Science 288, 2354-2357 |
| 24. | Romoser, V. A., Hinkle, P. M., and Persechini, A. (1997) J. Biol. Chem. 272, 13270-13274 |
| 25. | Persechini, A., Lynch, J. A., and Romoser, V. A. (1997) Cell Calcium 22, 209-216 |
| 26. | Miyawaki, A., Llopis, J., Heim, R., McCaffery, J. M., Adams, J. A., Ikura, M., and Tsien, R. Y. (1997) Nature 388, 882-887 |
| 27. | Persechini, A., and Cronk, B. (1999) J. Biol. Chem. 274, 6827-6830 |
| 28. | Pearce, L. L., Gandley, R. E., Han, W., Wasserloos, K., Stitt, M., Kanai, A. J., McLaughlin, M. K., Pitt, B. R., and Levitan, E. S. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 477-482 |
| 29. | Sato, M., Hida, N., Ozawa, T., and Umezawa, Y. (2000) Anal. Chem. 72, 5918-5924 |
| 30. | Honda, A., Adams, S. R., Sawyer, C. L., Lev-Ram, V., Tsien, R. Y., and Dostmann, W. R. G. (2001) Proc. Natl. Acad. Sci. U. S. A. 98, 2437-2442 |
| 31. | Mahajan, N. P., Harrison-Shostak, D. C., Michaux, J., and Herman, B. (1999) Chem. Biol. 6, 401-409 |
| 32. | Vanderklish, P. W., Krushel, L. A., Holst, B. H., Gaily, J. A., Crossin, K. L., and Edelman, G. M. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 2253-2258 |
| 33. | Nagai, Y., Miyazaki, M., Aoki, R., Zama, T., Inouye, S., Hirose, K., Iino, M., and Hagiwara, M. (2000) Nat. Biotechnol. 18, 313-316 |
| 34. | Baird, G. S., Zacharias, D. A., and Tsien, R. Y. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 11241-11246 |
| 35. | Heikal, A. A., Hess, S. T., Baird, G. S., Tsien, R. Y., and Webb, W. W. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 11996-12001 |
| 36. | Kendall, J. M., Dormer, R. L., and Campbell, A. K. (1992) Biochem. Biophys. Res. Comm. 189, 1008-1016 |
| 37. | Otwinowski, Z., and Minor, W. (1997) Methods Enzymol. 276, 307-326 |
| 38. | Brunger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., Read, R. J., Rice, L. M., Simonson, T., and Warren, G. L. (1998) Acta Cryst. D Biol. Cryst. 54, 905-921 |
| 39. | McRee, D. E. (1999) J. Struct. Biol. 125, 156-165 |
| 40. | Laskowski, R. A., MacArthur, M. W., Moss, D. S., and Thornton, J. M. (1993) J. Appl. Cryst. 26, 283-291 |
| 41. | Sanner, M. F., Olson, A. J., and Spehner, J. C. (1996) Biopolymers 38, 305-320 |
| 42. | Baird, G. S., Zacharias, D. A., and Tsien, R. Y. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 11984-11989 |
| 43. | Chesler, M., and Kaila, K. (1992) Trends Neurosci. 15, 396-402 |
| 44. | Kuner, T., and Augustine, G. J. (2000) Neuron 27, 447-459 |
| 45. | Nagai, T., Sawano, A., Park, E., and Miyawaki, A. (2001) Proc. Natl. Acad. Sci. U. S. A. 98, 3197-3202 |
| 46. | Rizzuto, R., Pinton, P., Carrington, W., Fay, F. S., Fogarty, K. E., Lifshitz, L. M., Tuft, R. A., and Pozzan, T. (1998) Science 280, 1763-1766 |
| 47. | Nakai, J., Ohkura, M., and Imoto, K. (2001) Nat. Biotechnol. 19, 137-141 |
| 48. | Kim, J. H., Johannes, L., Goud, B., Antony, C., Lingwood, C. A., Daneman, R., and Grinstein, S. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 2997-3002 |
| 49. | Pinton, P., Pozzan, T., and Rizzuto, R. (1998) EMBO J. 17, 5298-5308 |
| 50. | Lawrence, M. C., and Bourke, P. D. (2000) J. Appl. Cryst. 33, 990-991 |
| 51. | Kraulis, P. J. (1991) J. Appl. Cryst. 24, 946-950 |
This article has been cited by other articles:
![]() |
T. Hendel, M. Mank, B. Schnell, O. Griesbeck, A. Borst, and D. F. Reiff Fluorescence Changes of Genetic Calcium Indicators and OGB-1 Correlated with Neural Activity and Calcium In Vivo and In Vitro J. Neurosci., July 16, 2008; 28(29): 7399 - 7411. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. V. Thompson and S. M. Wolniak A Plasma Membrane-Anchored Fluorescent Protein Fusion Illuminates Sieve Element Plasma Membranes in Arabidopsis and Tobacco Plant Physiology, April 1, 2008; 146(4): 1599 - 1610. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Hires, Y. Zhu, and R. Y. Tsien Optical measurement of synaptic glutamate spillover and reuptake by linker optimized glutamate-sensitive fluorescent reporters PNAS, March 18, 2008; 105(11): 4411 - 4416. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Bharucha, J. R. Larson, L. Gao, L. K. Daves, and K. Tatchell Ypi1, a Positive Regulator of Nuclear Protein Phosphatase Type 1 Activity in Saccharomyces cerevisiae Mol. Biol. Cell, March 1, 2008; 19(3): 1032 - 1045. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jose, D. K. Nair, W. D. Altrock, T. Dresbach, E. D. Gundelfinger, and W. Zuschratter Investigating Interactions Mediated by the Presynaptic Protein Bassoon in Living Cells by Foerster's Resonance Energy Transfer and Fluorescence Lifetime Imaging Microscopy Biophys. J., February 15, 2008; 94(4): 1483 - 1496. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. H. Murphy, P. Li, K. Betts, and R. Liu Two-Photon Imaging of Stroke Onset In Vivo Reveals That NMDA-Receptor Independent Ischemic Depolarization Is the Major Cause of Rapid Reversible Damage to Dendrites and Spines J. Neurosci., February 13, 2008; 28(7): 1756 - 1772. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pedersen, M. Carmosino, and B. Forbush Intramolecular and Intermolecular Fluorescence Resonance Energy Transfer in Fluorescent Protein-tagged Na-K-Cl Cotransporter (NKCC1): SENSITIVITY TO REGULATORY CONFORMATIONAL CHANGE AND CELL VOLUME J. Biol. Chem., February 1, 2008; 283(5): 2663 - 2674. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. W. M. Nausch, J. Ledoux, A. D. Bonev, M. T. Nelson, and W. R. Dostmann Differential patterning of cGMP in vascular smooth muscle cells revealed by single GFP-linked biosensors PNAS, January 8, 2008; 105(1): 365 - 370. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. J. Shyu, C. D. Suarez, and C.-D. Hu Visualization of AP-1 NF-{kappa}B ternary complexes in living cells by using a BiFC-based FRET PNAS, January 8, 2008; 105(1): 151 - 156. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Raykhel, H. Alanen, K. Salo, J. Jurvansuu, V. D. Nguyen, M. Latva-Ranta, and L. Ruddock A molecular specificity code for the three mammalian KDEL receptors J. Cell Biol., December 17, 2007; 179(6): 1193 - 1204. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. C. Shaner, G. H. Patterson, and M. W. Davidson Advances in fluorescent protein technology J. Cell Sci., December 15, 2007; 120(24): 4247 - 4260. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dalal and M. Klemba Roles for Two Aminopeptidases in Vacuolar Hemoglobin Catabolism in Plasmodium falciparum J. Biol. Chem., December 7, 2007; 282(49): 35978 - 35987. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, S. N. Zolov, C. Y. Chow, S. G. Slutsky, S. C. Richardson, R. C. Piper, B. Yang, J. J. Nau, R. J. Westrick, S. J. Morrison, et al. Loss of Vac14, a regulator of the signaling lipid phosphatidylinositol 3,5-bisphosphate, results in neurodegeneration in mice PNAS, October 30, 2007; 104(44): 17518 - 17523. [Abstract] [Full Text] [PDF] |